Fig. 2From: Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective studyPercent changes from baseline in bone mineral density (BMD) at the lumbar spine (a) and femoral neck (b). Open and closed circles indicate the switching group (group 1) and continuous MIN group (group 2), respectively. Data are shown as mean ± standard error (SE). #P < 0.05, ##P < 0.01 change from baseline within each treatment group. *P < 0.05, **P < 0.01 Group 1 versus Group 2Back to article page